Treatment of patients with relapsed/refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: prospective evaluation of the impact of cytogenetic abnormalities and of previous therapies (Q42925566)
scientific article published on 26 August 2010
Language:
(P31) (Q13442814)
(P50) (Q26338766)
(Q43187559)
(P304) 1769-1778
(P407) (Q1860)
(P433) 10
(P478) 24
(P577) Thursday, August 26, 2010
(P921) (Q422252)
(Q467635)
(P1433) (Q6534498)
(P1476) "Treatment of patients with relapsed/refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: prospective evaluation of the impact of cytogenetic abnormalities and of previous therapies" (language: en)
(P2093) D Christoulas
M Migkou
M Gavriatopoulou
M Gkotzamanidou
M Iakovaki
C Matsouka
D Mparmparoussi
M Roussou
E Efstathiou
E Terpos
(P2860) (Q33377526)
(Q34585268)
(Q33289791)
(Q44211035)
(Q44010411)
(Q33386405)
(Q35848356)
(Q53243787)
(Q34549410)
(Q46068547)
(Q33383048)
(Q37268930)
(Q37028638)
(Q35848978)
(Q53246749)
(Q33284138)
(Q44620764)
(Q43195076)
(Q46733366)
(Q44183553)
(Q46726012)
(Q45129141)
(Q46937913)
(Q33363081)
(Q35848744)
(Q43018499)
(Q58050810)
(Q80776203)
(Q83930160)
(Q80011690)
(Q79345406)
(Q80332885)
(Q79560726)
(Q83305747)
(Q34166574)
other details
description scientific article published on 26 August 2010

External Links